Sichuan Kelun Pharmaceutical Statistics

Total Valuation

Sichuan Kelun Pharmaceutical has a market cap or net worth of CNY 49.40 billion. The enterprise value is 51.71 billion.

Market Cap	49.40B
Enterprise Value	51.71B

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Oct 23, 2024

Share Statistics

Sichuan Kelun Pharmaceutical has 1.59 billion shares outstanding. The number of shares has increased by 2.14% in one year.

Current Share Class	n/a
Shares Outstanding	1.59B
Shares Change (YoY)	+2.14%
Shares Change (QoQ)	-0.51%
Owned by Insiders (%)	27.15%
Owned by Institutions (%)	28.08%
Float	1.06B

Valuation Ratios

The trailing PE ratio is 16.45 and the forward PE ratio is 16.32.

PE Ratio	16.45
Forward PE	16.32
PS Ratio	2.14
PB Ratio	2.19
P/TBV Ratio	n/a
P/FCF Ratio	20.49
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.33, with an EV/FCF ratio of 21.44.

EV / Earnings	17.45
EV / Sales	2.30
EV / EBITDA	9.33
EV / EBIT	12.04
EV / FCF	21.44

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.22.

Current Ratio	1.88
Quick Ratio	1.35
Debt / Equity	0.22
Debt / EBITDA	1.03
Debt / FCF	2.37
Interest Coverage	20.42

Financial Efficiency

Return on equity (ROE) is 14.14% and return on invested capital (ROIC) is 8.66%.

Return on Equity (ROE)	14.14%
Return on Assets (ROA)	7.22%
Return on Capital (ROIC)	8.66%
Revenue Per Employee	1.14M
Profits Per Employee	149,698
Employee Count	19,798
Asset Turnover	0.61
Inventory Turnover	3.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.79% in the last 52 weeks. The beta is 0.05, so Sichuan Kelun Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	+12.79%
50-Day Moving Average	31.62
200-Day Moving Average	30.44
Relative Strength Index (RSI)	39.04
Average Volume (20 Days)	20,535,889

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sichuan Kelun Pharmaceutical had revenue of CNY 22.50 billion and earned 2.96 billion in profits. Earnings per share was 1.89.

Revenue	22.50B
Gross Profit	11.65B
Operating Income	4.29B
Pretax Income	4.74B
Net Income	2.96B
EBITDA	5.49B
EBIT	4.29B
Earnings Per Share (EPS)	1.89

Full Income Statement

Balance Sheet

The company has 7.08 billion in cash and 5.72 billion in debt, giving a net cash position of 1.37 billion or 0.86 per share.

Cash & Cash Equivalents	7.08B
Total Debt	5.72B
Net Cash	1.37B
Net Cash Per Share	0.86
Equity (Book Value)	26.23B
Book Value Per Share	14.22
Working Capital	8.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.36 billion and capital expenditures -1.95 billion, giving a free cash flow of 2.41 billion.

Operating Cash Flow	4.36B
Capital Expenditures	-1.95B
Free Cash Flow	2.41B
FCF Per Share	1.52

Full Cash Flow Statement

Margins

Gross margin is 51.76%, with operating and profit margins of 19.09% and 13.17%.

Gross Margin	51.76%
Operating Margin	19.09%
Pretax Margin	21.07%
Profit Margin	13.17%
EBITDA Margin	24.39%
EBIT Margin	19.09%
FCF Margin	10.72%

Dividends & Yields

This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 1.70%.

Dividend Per Share	0.52
Dividend Yield	1.70%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	47.36%
Buyback Yield	-2.14%
Shareholder Yield	-0.44%
Earnings Yield	6.08%
FCF Yield	4.88%

Dividend Details

Stock Splits

The last stock split was on July 22, 2015. It was a forward split with a ratio of 2.

Last Split Date	Jul 22, 2015
Split Type	Forward
Split Ratio	2

Scores

Sichuan Kelun Pharmaceutical has an Altman Z-Score of 3.94.

Altman Z-Score	3.94
Piotroski F-Score	n/a